Crossmark

Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis

Crossref DOI link: https://doi.org/10.1007/s10792-018-0955-6

Published Online: 2018-06-19

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deepthi, S.

Jose, Jobin
License Information

Text and Data Mining valid from 2018-06-19
More Information

Article History

Received: 16 August 2017

Accepted: 12 June 2018

First Online: 19 June 2018

Compliance with ethical standards

:

: The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

: All procedures performed in studies involving animals were in accordance with the ethical standards of the institutional and/or national research committee or comparable ethical standards.